Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Department of Health and Human Services, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Bill Cassidy, all published on August 4, 2026.
Last mentioned: Aug 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Department of Health and Human Services, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Bill Cassidy, all published on August 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bill Cassidy. Shared-story counts are live from our verified record — not editorial picks.
Senator Bill Cassidy's public denouncement of HHS Secretary Kennedy for building health policy on lies injects fresh uncertainty into the biotech and pharma industry. Vaccine research and markets face headwinds if top federal officials continue to sow distrust, potentially altering investment and development pipelines.
Source: cbsnews.com · yahoo.com
Bill Cassidy is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
